General Wellness

The Role of Taste in Regulating Eating Habits: Insights From New Research

24 May 2024 3 min read Reviewed by a Heathershaw's pharmacist
Person eating a meal at a table

New research suggests the taste of food itself, not just signals from your gut, helps set the pace at which you eat.

Researchers have long believed that the sensation of fullness, and the natural slowing of eating pace that comes with it, was driven mainly by signals travelling from the stomach and intestines to the brain. A new study from a research lab at UC San Francisco has identified a second, separate pathway that begins the moment food is tasted.

Two pathways, not one

The study, conducted in mice using new neuron-monitoring techniques, found two parallel systems at play: one that paces how quickly you eat, and another that limits how much you eat overall. The first pathway is switched on by taste itself, and appears to unconsciously slow eating speed even as a pleasant taste might otherwise encourage you to eat more.

Where GLP-1 fits in

The second pathway relies on neurons that release the hormone GLP-1, creating a longer-lasting sense of fullness. This is the same hormone that newer weight-management medicines, like semaglutide, work to mimic and prolong. Understanding how these two systems interact may help researchers refine how these medicines are used, and potentially identify other approaches to appetite regulation down the track.

This research is still early-stage and based on animal studies. It adds to the broader picture of how satiety works, rather than changing anything about how weight-management medicines are currently prescribed.

More from the blog

Weight Loss

GLP-1 Agonist May Reduce COVID-19 Deaths, Study Suggests

A trial designed to study heart health turned up a surprising result linked to COVID-19 outcomes.

Read more
Weight Loss

Ozempic and Wegovy - What is the Difference?

Same active ingredient, different approvals. Here's what actually separates Ozempic from Wegovy in Australia.

Read more
Weight Loss

Research Shows GLP-1 Agonists Reduce Kidney Disease Risk in Diabetes Patients

A major trial found real kidney and cardiovascular benefits for people managing both diabetes and chronic kidney disease.

Read more

Still have a question?

Our pharmacists are happy to help, at any of our four Melbourne locations, or online.